Factors like genetics, body type, and keeping up with lifestyle changes can affect how you do
Eli Lilly has seven Phase 3 trials expected to report results in 2026, with potential FDA approval projected for 2027
The result can be a more balanced approach to fat loss when paired with a clean diet and consistent training
Unlike compounds that target a single receptor, retatrutide serves as a model for research into the complex regulation of glucose homeostasis, lipid metabolism and energy balance
Its structure, anchored in pharmacologic rationale, real-world feasibility, and patient safety, enables near-term implementation even as multicenter studies further define optimal hold durations, ultrasound cut-offs, and fertility outcomes